
FDA approves first postpartum depression drug
For the first time in history, the US Food and Drug Administration has approved a drug specifically indicated for the treatment of postpartum depression, which experts say offers new hope to women and physicians. The FDA announced the approval of an intravenous infusion of the drug brexanolone, which will be sold as Zulresso. It has been shown in clinical trials to work within hours to treat the symptoms of postpartum depression, a serious mental illness that impacts 1 in 9 new mothers after childbirth. CNN's Dr. Sanjay Gupta reports.
02:00
- Source:
CNN
Stories worth watching
16 videos

Father charged with killing his wife and son. See his interview with investigators

'The system is stressed to the max': United CEO weighs in on industry woes

Why Goldman Sachs says a recession isn't coming
02:18
Now playing
- Source:
CNN Business

Jimmy Kimmel fears this bet will get him slapped while hosting the Oscars

A New York mugging and bad checks: Podcaster reveals Santos' latest wild claims

Disney is closing an iconic ride. Hear why some fans aren't happy about it

Hear conservative complaints about changes to M&M'S chocolate characters
01:42
Now playing
- Source:
CNN Business